New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2013
08:09 EDTMDASMedAssets pullback brings attractive entry point, says Lazard Capital
Lazard Capital says the recent pullback in shares of MedAssets provides an attractive entry point as it does not see any change in the company's fundamentals. The firm reiterates a Buy rating on the name with a $22 price target.
News For MDAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2015
10:01 EDTMDASOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:04 EDTMDASMedAssets downgraded to Market Perform from Outperform at Cowen
Cowen downgraded MedAssets to Market Perform and lowered its price target to $22 from $25. The firm believes shares reflect optimism around a transformative corporate event such as a split between the SCM and RCM segments, that is less likely to happen.
July 14, 2015
10:01 EDTMDASOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:41 EDTMDASMedAssets downgraded to Hold from Buy at Evercore ISI
Subscribe for More Information
05:55 EDTMDASMedAssets downgraded to Hold from Buy at Evercore ISI
Subscribe for More Information
July 13, 2015
05:55 EDTMDASMedAssets estimates lowered on St. Barnabas loss at Piper Jaffray
Piper Jaffray notes MedAssets lost the GPO business of St. Barnabas, a 2,700 bed health system in New Jersey, to competitor Healthtrust Purchasing Group, effective September 1. Piper estimates the contract is worth up to $8M per year to MedAssets. The firm lowered its estimates for the company and sees the potential for further contract losses given the management turnover. It reiterates an Underweight rating on MedAssets with a $15 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use